Salazar, Reynante S.
HRN: 01-58-53 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/23/2022
CEFTRIAXONE 1G (VIAL)
06/23/2022
06/29/2022
IV
1g
Q12
Multiple Soft Tissue Injury
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes